Screener
TransMedics Group, Inc. TMDX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by TransMedics Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206453
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 10) | ||
| Stockholders’ equity: | ||
| Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding | — | — |
| Common stock, no par value; 150,000,000 shares authorized; 34,545,721 shares and 34,267,802 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 764,640 | 750,926 |
| Accumulated other comprehensive income | 2 | 124 |
| Accumulated deficit | (270,635) | (277,950) |
| Total stockholders’ equity | 494,007 | 473,100 |
| Total liabilities and stockholders’ equity | $1,434,820 | $1,068,373 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is TransMedics Group, Inc.'s total equity?
- TransMedics Group, Inc. (TMDX) reported total equity of $494.01M in Q1 2026.
- How has TransMedics Group, Inc.'s total equity changed year-over-year?
- TransMedics Group, Inc.'s total equity increased by 85.5% year-over-year, from $266.31M to $494.01M.
- What is the long-term trend for TransMedics Group, Inc.'s total equity?
- Over 5 years (2020 to 2025), TransMedics Group, Inc.'s total equity has grown at a 35.4% compound annual growth rate (CAGR), from $103.89M to $473.1M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about TransMedics Group, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude